An emerging generation of endocrine therapies in breast cancer: a clinical perspective
New Therapy Targets Breast Cancer Metastases in Brain
Cancers, Free Full-Text
Randomized Phase II Trial of Fulvestrant Plus Everolimus or
The immunomodulatory effects of endocrine therapy in breast cancer, Journal of Experimental & Clinical Cancer Research
Current and Upcoming Treatment Strategies After CDK4/6 Inhibitors
Randomized Phase II Trial of Fulvestrant Plus Everolimus or
ZB716, a steroidal selective estrogen receptor degrader (SERD), is
ZB716, a steroidal selective estrogen receptor degrader (SERD), is
Pharmaceutics, Free Full-Text
IJMS, Free Full-Text
Cancers, Free Full-Text
New Insights into Extracellular Vesicles between Adipocytes and
Randomized Phase II Trial of Fulvestrant Plus Everolimus or
Systemic Therapy for Estrogen Receptor–Positive, HER2-Negative
Endocrine treatment in breast cancer: Cure, resistance and beyond